10
Participants
Start Date
December 9, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
February 28, 2025
Amoxicillin
Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Levofloxacin
Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Ofloxacin
Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
Sulfamethoxazole trimethoprim
Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally
RECRUITING
CHRU Nancy, Vandœuvre-lès-Nancy
Collaborators (1)
Société Francophone Nutrition Clinique et Métabolisme
OTHER
FIlière des Maladies rares Abdomino-THOraciques
UNKNOWN
Fresenius Kabi
INDUSTRY
Central Hospital, Nancy, France
OTHER